arrow
C

Charles Zou

Yale University School of Medicine
H指数:10
被引数:1,147

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours

作者更正:OR7A10 GPCR工程改造增强了CAR-NK疗法对实体瘤的治疗效果

Nature
IF48.5
2026-07-130
PREAI
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours

OR7A10 GPCR工程改造增强了CAR-NK疗法对实体瘤的治疗效果

Nature
IF48.5
2026-02-250
PRE
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradation

扩展可成药的锌指蛋白质组界定了药物诱导降解的特性

2025-08-210
OAAI
Template-assisted covalent modification underlies activity of covalent molecular glues

模板辅助的共价修饰是共价分子胶活性的基础

2024-07-295
OAAI
Genetic retargeting of E3 ligases to enhance CAR T cell therapy
2024-02-017
PRE
Design principles for cyclin K molecular glue degraders
2023-09-0718
OAAI
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability
2023-08-0121
OAAI
Template-assisted covalent modification of DCAF16 enables BRD4 molecular glue degraders
2023-04-040
PRE
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells
2022-08-1526
OAAI
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition (vol 24, pg 968, 2018)
2018-08-093
OAAI
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
2018-05-28219
OAAI